Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sinntaxis, founded in 2017 by Lund University scientists and LU Holding AB, is a neuroscience company specializing in stroke recovery therapeutics. Our experienced team combines expertise in neuroscience, pharmaceutical development, and business strategy. We have developed a proprietary discovery platform for preclinical stroke research and hold intellectual property on negative allosteric modulators of mGluR5 for post-stroke ...
Sinntaxis, founded in 2017 by Lund University scientists and LU Holding AB, is a neuroscience company specializing in stroke recovery therapeutics. Our experienced team combines expertise in neuroscience, pharmaceutical development, and business strategy. We have developed a proprietary discovery platform for preclinical stroke research and hold intellectual property on negative allosteric modulators of mGluR5 for post-stroke recovery.

List your booth number for exhibitions, ask us